Liang Su
About
Liang Su has authored 20 papers that have received a total of 842 indexed citations.
This includes 10 papers in Molecular Biology, 5 papers in Infectious Diseases and 4 papers in Oncology. The topics of these papers are COVID-19 Clinical Research Studies (3 papers), Peptidase Inhibition and Analysis (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Liang Su is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Peptidase Inhibition and Analysis (2 papers) and Nanoparticle-Based Drug Delivery (2 papers) and collaborates with scholars based in China and United States. Liang Su's co-authors include Dong Liang, Huan Xie, Cheng‐Bao Zhu, Jing Ma and Jianjun Paul Tian and has published in prestigious journals such as ACS Nano, PLoS ONE and Frontiers in Immunology
In The Last Decade
Explore authors with similar magnitude of impact
Top fields papers by George N. Ike are about Top journals papers by Hazel C. Cable are published in Top authors papers by A. O’Meara are co-authored with Top countries impacted by papers by Mary Ellen Morbeck Top authors papers by Todd Bartkowiak are co-authored with Top fields papers by Elena Dukhovlinova are about Top authors papers by Matthias Totzeck are co-authored with Top journals papers by Kameron V. Kilchrist are published in